-- 週四,美國股指期貨走低,美伊和平談判未見明顯進展,交易員們正在消化特斯拉(TSLA)的最新財報。 標普500指數、那斯達克指數盤前交易均下跌0.6%,道瓊工業指數下跌0.7%。週三,各大股指均收漲,標普500指數和那斯達克指數在連續兩日下跌後均創下歷史新高。 據報道,華盛頓和德黑蘭本週將舉行新一輪談判,但迄今尚未成行,伊朗繼續封鎖霍爾木茲海峽。美國副總統萬斯在伊朗拒絕參加談判後取消了前往巴基斯坦的行程。 本週早些時候,川普總統延長了與伊朗的停火協議,但他表示,對伊朗港口的海上封鎖將繼續。據報道,伊朗伊斯蘭革命衛隊週三宣布扣押了兩艘試圖穿越霍爾木茲海峽的油輪。 西德州中質原油開盤前上漲1.8%,每桶94.60美元;布蘭特原油上漲1.7%,至每桶103.59美元。 盛寶銀行大宗商品策略主管奧勒·漢森週三在一份報告中表示:“由於交易員對混亂且往往自相矛盾的新聞報道做出反應,油價持續劇烈波動,凸顯了德黑蘭和華盛頓之間根深蒂固的不信任。” 儘管電動車製造商特斯拉(TSLA)公佈的第一季業績強於預期,但其股價在盤前交易中仍下跌了3.3%。根據FactSet發布的電話會議記錄顯示,財務長Vaibhav Taneja在周三晚間的電話會議上表示,該公司預計2026年的資本支出將超過250億美元,這將導致今年剩餘時間的自由現金流為負。 Wedbush Securities在周四的一份客戶報告中指出:“特斯拉正在轉型成為實體(人工智慧)領域的領導者。轉型之路已經到來,但這需要更多的(資本支出)。” ServiceNow (NOW)股價下跌13%,IBM股價下跌7.1%,此前兩家公司公佈了最新的季度業績。台積電(TSM)在美國上市的股票下跌1.4%。 美國運通(AXP)、賽默飛世爾科技(TMO)、聯合太平洋(UNP)、霍尼韋爾國際(HON)、洛克希德·馬丁(LMT)、康卡斯特(CMCSA)、印孚瑟斯(INFY)和Keurig Dr Pepper (KDP)等公司將在盤前公佈財報。英特爾 (INTC) 將於市場收盤後發布業績報告。 週四的經濟數據包括:美國東部時間上午 8:30 公佈的每周初請失業金人數,以及芝加哥聯邦儲備銀行 3 月份的全國經濟活動指數。標普全球 (SPGI) 4 月份採購經理人指數初值將於上午 9:45 公佈,堪薩斯市聯邦儲備銀行 4 月份製造業指數將於上午 11:00 公佈。 美國公債殖利率在盤前交易中走高,兩年期公債殖利率上漲 2.5 個基點至 3.82%,十年期公債殖利率上漲 2.7 個基點至 4.32%。 黃金價格下跌 1% 至每盎司 4,707 美元,比特幣價格下跌 1.8% 至每盎司 77,473 美元。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.